FMC - Charles City in Charles City, Iowa - Dialysis Center

FMC - Charles City is a medicare approved dialysis facility center in Charles City, Iowa and it has 8 dialysis stations. It is located in Floyd county at 707 Gilbert St, Charles City, IA, 50616. You can reach out to the office of FMC - Charles City at (641) 228-3567. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC - Charles City has the following ownership type - Profit. It was first certified by medicare in August, 2016. The medicare id for this facility is 162564 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameFMC - Charles City
Location707 Gilbert St, Charles City, Iowa
No. of Dialysis Stations 8
Medicare ID162564
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts No

Contact Information


707 Gilbert St, Charles City, Iowa, 50616
(641) 228-3567
Not Available

News Archive

AGA guidelines recommend RFA for removal of precancerous cells in patients with Barrett's esophagus

New guidelines issued by the American Gastroenterological Association (AGA) support the use of radiofrequency ablation (RFA) to remove precancerous cells in patients with Barrett's esophagus, a condition most commonly caused by chronic acid reflux, or GERD. Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans.

FDA approves new drug combination for hormone positive and HER2-positive advanced breast cancer

The U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.

LCA-Vision announces third quarter 2009 operational and financial results

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operating results for the three and nine months ended September 30, 2009.

Remdesivir inhibits SARS-CoV-2 replication by preventing RdRp-mediated RNA translocation

A new study describes the in vitro mechanism by which remdesivir kinetically inhibits the replication of the virus that causes COVID-19, SARS-CoV-2.

Churning, confusion and disruption — The dark side of marketplace coverage

Cyndee Weston can barely remember the last time she didn't have to switch health plans during an Affordable Care Act sign-up season. By her count, she has been on five plans in five years.

Read more Medical News

› Verified 8 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with FMC - Charles City from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1770939910
Organization NameFresenius Kidney Care Charles City
Doing Business AsFresenius Kidney Care North Iowa, Llc
Address707 Gilbert St Charles City, Iowa, 50616
Phone Number(641) 651-0163

News Archive

AGA guidelines recommend RFA for removal of precancerous cells in patients with Barrett's esophagus

New guidelines issued by the American Gastroenterological Association (AGA) support the use of radiofrequency ablation (RFA) to remove precancerous cells in patients with Barrett's esophagus, a condition most commonly caused by chronic acid reflux, or GERD. Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans.

FDA approves new drug combination for hormone positive and HER2-positive advanced breast cancer

The U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.

LCA-Vision announces third quarter 2009 operational and financial results

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operating results for the three and nine months ended September 30, 2009.

Remdesivir inhibits SARS-CoV-2 replication by preventing RdRp-mediated RNA translocation

A new study describes the in vitro mechanism by which remdesivir kinetically inhibits the replication of the virus that causes COVID-19, SARS-CoV-2.

Churning, confusion and disruption — The dark side of marketplace coverage

Cyndee Weston can barely remember the last time she didn't have to switch health plans during an Affordable Care Act sign-up season. By her count, she has been on five plans in five years.

Read more Medical News

› Verified 8 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data9

News Archive

AGA guidelines recommend RFA for removal of precancerous cells in patients with Barrett's esophagus

New guidelines issued by the American Gastroenterological Association (AGA) support the use of radiofrequency ablation (RFA) to remove precancerous cells in patients with Barrett's esophagus, a condition most commonly caused by chronic acid reflux, or GERD. Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans.

FDA approves new drug combination for hormone positive and HER2-positive advanced breast cancer

The U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.

LCA-Vision announces third quarter 2009 operational and financial results

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operating results for the three and nine months ended September 30, 2009.

Remdesivir inhibits SARS-CoV-2 replication by preventing RdRp-mediated RNA translocation

A new study describes the in vitro mechanism by which remdesivir kinetically inhibits the replication of the virus that causes COVID-19, SARS-CoV-2.

Churning, confusion and disruption — The dark side of marketplace coverage

Cyndee Weston can barely remember the last time she didn't have to switch health plans during an Affordable Care Act sign-up season. By her count, she has been on five plans in five years.

Read more Medical News

› Verified 8 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center21
    Adult patient months included in Kt/V greater than or equal to 1.2166
    Percentage of adult patients getting regular hemodialysis at the center93

    News Archive

    AGA guidelines recommend RFA for removal of precancerous cells in patients with Barrett's esophagus

    New guidelines issued by the American Gastroenterological Association (AGA) support the use of radiofrequency ablation (RFA) to remove precancerous cells in patients with Barrett's esophagus, a condition most commonly caused by chronic acid reflux, or GERD. Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans.

    FDA approves new drug combination for hormone positive and HER2-positive advanced breast cancer

    The U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.

    LCA-Vision announces third quarter 2009 operational and financial results

    LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operating results for the three and nine months ended September 30, 2009.

    Remdesivir inhibits SARS-CoV-2 replication by preventing RdRp-mediated RNA translocation

    A new study describes the in vitro mechanism by which remdesivir kinetically inhibits the replication of the virus that causes COVID-19, SARS-CoV-2.

    Churning, confusion and disruption — The dark side of marketplace coverage

    Cyndee Weston can barely remember the last time she didn't have to switch health plans during an Affordable Care Act sign-up season. By her count, she has been on five plans in five years.

    Read more Medical News

    › Verified 8 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC - Charles City with elevated calcium levels.

Patients with hypercalcemia22
Hypercalcemia patient months175
Hypercalcemia patients with serumcalcium greater than 10.2 mg3
Patients with Serumphosphor22
Patients with Serumphosphor less than 3.5 mg/dL7
Patients with Serumphosphor from 3.5 to 4.5 mg/dL31
Patients with Serumphosphor from 4.6 to 5.5 mg/dL35
Patients with Serumphosphor from 5.6 to 7 mg/dL20
Patients with Serumphosphor greater than 7 mg/dL7

News Archive

AGA guidelines recommend RFA for removal of precancerous cells in patients with Barrett's esophagus

New guidelines issued by the American Gastroenterological Association (AGA) support the use of radiofrequency ablation (RFA) to remove precancerous cells in patients with Barrett's esophagus, a condition most commonly caused by chronic acid reflux, or GERD. Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans.

FDA approves new drug combination for hormone positive and HER2-positive advanced breast cancer

The U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.

LCA-Vision announces third quarter 2009 operational and financial results

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operating results for the three and nine months ended September 30, 2009.

Remdesivir inhibits SARS-CoV-2 replication by preventing RdRp-mediated RNA translocation

A new study describes the in vitro mechanism by which remdesivir kinetically inhibits the replication of the virus that causes COVID-19, SARS-CoV-2.

Churning, confusion and disruption — The dark side of marketplace coverage

Cyndee Weston can barely remember the last time she didn't have to switch health plans during an Affordable Care Act sign-up season. By her count, she has been on five plans in five years.

Read more Medical News

› Verified 8 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 22
Patient months included in arterial venous fistula and catheter summaries 114
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment53
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer33

News Archive

AGA guidelines recommend RFA for removal of precancerous cells in patients with Barrett's esophagus

New guidelines issued by the American Gastroenterological Association (AGA) support the use of radiofrequency ablation (RFA) to remove precancerous cells in patients with Barrett's esophagus, a condition most commonly caused by chronic acid reflux, or GERD. Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans.

FDA approves new drug combination for hormone positive and HER2-positive advanced breast cancer

The U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.

LCA-Vision announces third quarter 2009 operational and financial results

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operating results for the three and nine months ended September 30, 2009.

Remdesivir inhibits SARS-CoV-2 replication by preventing RdRp-mediated RNA translocation

A new study describes the in vitro mechanism by which remdesivir kinetically inhibits the replication of the virus that causes COVID-19, SARS-CoV-2.

Churning, confusion and disruption — The dark side of marketplace coverage

Cyndee Weston can barely remember the last time she didn't have to switch health plans during an Affordable Care Act sign-up season. By her count, she has been on five plans in five years.

Read more Medical News

› Verified 8 days ago


Dialysis Facility in Charles City, IA

FMC - Charles City
Location: 707 Gilbert St, Charles City, Iowa, 50616
Phone: (641) 228-3567

News Archive

AGA guidelines recommend RFA for removal of precancerous cells in patients with Barrett's esophagus

New guidelines issued by the American Gastroenterological Association (AGA) support the use of radiofrequency ablation (RFA) to remove precancerous cells in patients with Barrett's esophagus, a condition most commonly caused by chronic acid reflux, or GERD. Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans.

FDA approves new drug combination for hormone positive and HER2-positive advanced breast cancer

The U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.

LCA-Vision announces third quarter 2009 operational and financial results

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operating results for the three and nine months ended September 30, 2009.

Remdesivir inhibits SARS-CoV-2 replication by preventing RdRp-mediated RNA translocation

A new study describes the in vitro mechanism by which remdesivir kinetically inhibits the replication of the virus that causes COVID-19, SARS-CoV-2.

Churning, confusion and disruption — The dark side of marketplace coverage

Cyndee Weston can barely remember the last time she didn't have to switch health plans during an Affordable Care Act sign-up season. By her count, she has been on five plans in five years.

Read more Medical News

› Verified 8 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.